However, in our study, we observed a completely reversed landscape of transcript expression: mRNAs of IFITM1, RSAD2, and IFNB1 genes were well presented almost in all GBM cells studied, except for Gbl25n defective for type I IFNs and subsequent ISGs (Supplementary Table S2). This evidence concerns the gene RSAD2 and glioblastoma.